Continuing GLP-1/GIP agonist therapy prior to elective upper endoscopy increases the risk for residual gastric volume, but clear liquids the day before could mitigate the risk.
Patients on GLP-1 or GLP-1/GIP agonists had significant residual gastric volume (RGV) if the medication wasn't held prior to upper endoscopy unless they were on a clear liquid diet the day before, the ...
Abstract: Recent advancements toward perception and decision-making of flexible endoscopes have shown great potential in computer-aided surgical interventions. However, owing to modeling uncertainty ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results